BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 16680246)

  • 21. Dissemination of SHV-12 and CTX-M-type extended-spectrum beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea.
    Ryoo NH; Kim EC; Hong SG; Park YJ; Lee K; Bae IK; Song EH; Jeong SH
    J Antimicrob Chemother; 2005 Oct; 56(4):698-702. PubMed ID: 16141280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and characterization of extended-spectrum beta-lactamase-producing Enterobacteriaceae isolated in Korean hospitals.
    Ko KS; Lee MY; Song JH; Lee H; Jung DS; Jung SI; Kim SW; Chang HH; Yeom JS; Kim YS; Ki HK; Chung DR; Kwon KT; Peck KR; Lee NY
    Diagn Microbiol Infect Dis; 2008 Aug; 61(4):453-9. PubMed ID: 18482815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of clinical isolates of Escherichia coli and Klebsiella spp. producing multiple extended-spectrum beta-lactamases.
    Romero ED; Padilla TP; Hernández AH; Grande RP; Vázquez MF; García IG; García-Rodríguez JA; Muñoz Bellido JL
    Diagn Microbiol Infect Dis; 2007 Dec; 59(4):433-7. PubMed ID: 17913435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High prevalence of extended-spectrum beta-lactamases and plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae isolated from long-term care facilities in Korea.
    Yoo JS; Byeon J; Yang J; Yoo JI; Chung GT; Lee YS
    Diagn Microbiol Infect Dis; 2010 Jul; 67(3):261-5. PubMed ID: 20462727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiological and antibiotic resistant study on extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Zhejiang Province.
    Yu Y; Zhou W; Chen Y; Ding Y; Ma Y
    Chin Med J (Engl); 2002 Oct; 115(10):1479-82. PubMed ID: 12490091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and types of extended-spectrum beta-lactamases among urinary Escherichia coli and Klebsiella spp. in New Zealand.
    Heffernan HM; Woodhouse RE; Pope CE; Blackmore TK
    Int J Antimicrob Agents; 2009 Dec; 34(6):544-9. PubMed ID: 19748232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
    Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J
    J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae isolated in a rural hospital.
    Basak S; Mallick SK; Bose S
    J Indian Med Assoc; 2009 Dec; 107(12):855-8. PubMed ID: 20509468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae acquisition in a neonatal intensive care unit.
    Shakil S; Ali SZ; Akram M; Ali SM; Khan AU
    J Trop Pediatr; 2010 Apr; 56(2):90-6. PubMed ID: 19608665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activities of 16 antimicrobial agents against clinical isolates of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in two regional hospitals in Taiwan.
    Liao CH; Sheng WH; Wang JT; Sun HY; Wang HK; Hsueh PR; Chen YC; Chang SC
    J Microbiol Immunol Infect; 2006 Feb; 39(1):59-66. PubMed ID: 16440125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and significance of a negative extended-spectrum beta-lactamase (ESBL) confirmation test result after a positive ESBL screening test result for isolates of Escherichia coli and Klebsiella pneumoniae: results from the SENTRY Asia-Pacific Surveillance Program.
    Bell JM; Chitsaz M; Turnidge JD; Barton M; Walters LJ; Jones RN
    J Clin Microbiol; 2007 May; 45(5):1478-82. PubMed ID: 17344367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial susceptibility pattern and prevalence of extended spectrum beta-lactamase (ESBLs) producing strains of Klebsiella pneumoniae from a major hospital in New Delhi.
    Grover SS; Sharma M; Pasha ST; Singh G; Lal S
    J Commun Dis; 2004 Mar; 36(1):17-26. PubMed ID: 16295682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prevalence and susceptibility patterns of extended-spectrum betalactamase-producing Escherichia coli and Klebsiella pneumoniae in a general university hospital in Beirut, Lebanon].
    Daoud Z; Hakime N
    Rev Esp Quimioter; 2003 Jun; 16(2):233-8. PubMed ID: 12973463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of tigecycline and molecular characterization of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from a university hospital in south-western Germany.
    Wienke M; Pfeifer Y; Weissgerber P; Marschal M; Autenrieth IB; Gröbner S
    Chemotherapy; 2012; 58(3):241-8. PubMed ID: 22832033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and antimicrobial susceptibility pattern of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the United Arab Emirates.
    Al-Zarouni M; Senok A; Rashid F; Al-Jesmi SM; Panigrahi D
    Med Princ Pract; 2008; 17(1):32-6. PubMed ID: 18059098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prevalence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates from a general hospital in Iran.
    Bazzaz BS; Naderinasab M; Mohamadpoor AH; Farshadzadeh Z; Ahmadi S; Yousefi F
    Acta Microbiol Immunol Hung; 2009 Mar; 56(1):89-99. PubMed ID: 19388560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health and economic outcomes of the detection of Klebsiella pneumoniae-produced extended-spectrum beta-lactamase (ESBL) in a hospital with high prevalence of this infection.
    Marra AR; Pereira CA; Castelo A; do Carmo Filho JR; Cal RG; Sader HS; Wey SB
    Int J Infect Dis; 2006 Jan; 10(1):56-60. PubMed ID: 16326126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
    Romero L; López L; Rodríguez-Baño J; Ramón Hernández J; Martínez-Martínez L; Pascual A
    Clin Microbiol Infect; 2005 Aug; 11(8):625-31. PubMed ID: 16008614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and characterization of extended-spectrum beta-lactamases in Klebsiella pneumoniae and Escherichia coli isolates from Colombian hospitals.
    Villegas MV; Correa A; Perez F; Miranda MC; Zuluaga T; Quinn JP;
    Diagn Microbiol Infect Dis; 2004 Jul; 49(3):217-22. PubMed ID: 15246513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella isolates in a large community teaching hospital in Connecticut.
    Dandekar PK; Tetreault J; Quinn JP; Nightingale CH; Nicolau DP
    Diagn Microbiol Infect Dis; 2004 May; 49(1):37-9. PubMed ID: 15135498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.